Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinics
Centre National de la Recherche Scientifique · Inserm · +22 more institutions
Abstract
Lecanemab, a monoclonal antibody targeting β-amyloid protofibrils, has shown promising results in a Phase III clinical trial for the treatment of early stages of Alzheimer's disease (AD) and has been approved by the European Medicines Agency. An Early Market Authorization could be submitted to the French regulatory agencies, potentially allowing for the drug's use in clinical practice in France in 2025. To guide French clinicians in administering lecanemab in a standardized way, the French Federation of Memory Clinics has developed appropriate use recommendations for lecanemab that highlight relevant questions established to ensure an optimal risk-benefit ratio. The recommendations emphasize that lecanemab…
Citation impact
- FWCI
- 55.20
- Percentile
- 100%
- References
- 114
Authors
8- NVNicolas VillainCorresponding
Centre National de la Recherche Scientifique, Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Institut du Cerveau
- VPVincent Planche
Centre National de la Recherche Scientifique, Université de Bordeaux, Centre Hospitalier Universitaire de Bordeaux, Institut des Maladies Neurodégénératives
- MLMatthieu Lilamand
Inserm, Université Paris Cité, Sorbonne Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Fernand-Widal, Hôpital Lariboisière, Optimisation Thérapeutique en Neuropsychopharmacologie
- CCCharlotte Cordonnier
Inserm, Université de Lille, Centre Hospitalier Universitaire de Lille, Centre de Recherche Jean Pierre Aubert, Lille Neurosciences & Cognition
- MSMaria Soto‐Martin
Université Toulouse III - Paul Sabatier, Inserm, Université Fédérale de Toulouse Midi-Pyrénées, Centre Hospitalier Universitaire de Toulouse, Centre de recherche en Epidémiologie et Santé des Populations
Topics & keywords
- Disease
- Russian federation
- Memory clinic
- Medicine
- Gerontology
- Psychology
- Psychiatry
- Dementia